Adipositas und Krebsrisiko

Übergewicht und Adipositas (definiert durch einen Body-Mass-Index [BMI] ≥ 25 kg/m² Körperoberfläche) stellen ein ernsthaftes und in der Prävalenz zunehmendes Gesundheitsrisiko dar. Gemäß einer aktuellen Studie zur Gesundheit Erwachsener in Deutschland (DEGS1) sind 67 % der Männer und 53 % der Frauen übergewichtig. Die Prävalenz der manifesten Adipositas (BMI ≥ 30 kg/m²) liegt für Männer bei 23,3 % und für Frauen bei 23,9 %. Im Vergleich dazu waren im Jahre 1998 nur ca. 19 % der Männer und ca. 22 % der Frauen in Deutschland adipös. Insbesondere bei Kindern, Jugendlichen und jungen Erwachsenen zeigte sich in der aktuellen Erhebung ein Anstieg der Adipositas-Prävalenz, was besonders bedenklich erscheint [1].

• Literatur

• 1 Mensink GB, Schienkiewitz A, Haftenberger M. et al. [Overweight and obesity in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013; 56: 786-794
• 2 Ligibel JA, Alfano CM, Courneya KS. et al. American Society of Clinical Oncology position statement on obesity and cancer. J Clin Oncol 2014; 32: 3568-3574
• 3 Baselga J, Senn HJ. European Society for Medical Oncology. The perspective and role of the medical oncologist in cancer prevention: a position paper by the European Society for Medical Oncology. Ann Oncol 2008; 19: 1033-1035
• 4 Dobbins M, Decorby K, Choi BC. The association between obesity and cancer risk: a meta-analysis of observational studies from 1985 to 2011. ISRN Prev Med 2013; 2013: 680536
• 5 Keum N, Greenwood DC, Lee DH. et al. Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies. J Natl Cancer Inst 2015;
• 6 Bhaskaran K, Douglas I, Forbes H. et al. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet 2014; 384: 755-765
• 7 Liesenfeld DB, Grapov D, Fahrmann JF. et al. Metabolomics and transcriptomics identify pathway differences between visceral and subcutaneous adipose tissue in colorectal cancer patients: the ColoCare study. Am J Clin Nutr 2015; 102: 433-443
• 8 Khandekar MJ, Cohen P, Spiegelman BM. Molecular mechanisms of cancer development in obesity. Nat Rev Cancer 2011; 11: 886-895
• 9 Protani M, Coory M, Martin JH. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat 2010; 123: 627-635
• 10 Sinicrope FA, Foster NR, Yothers G. et al. Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy. Cancer 2013; 119: 1528-1536
• 11 Byers T, Sedjo RL. Does intentional weight loss reduce cancer risk?. Diabetes Obes Metab 2011; 13: 1063-1072
• 12 Anderson AS, Key TJ, Norat T. et al. European code against cancer 4th edition: Obesity, body fatness and cancer. Cancer Epidemiol 2015;
• 13 Reeves MM, Terranova CO, Eakin EG. et al. Weight loss intervention trials in women with breast cancer: a systematic review. Obes Rev 2014; 15: 749-768
• 14 Cheema BS, Kilbreath SL, Fahey PP. et al. Safety and efficacy of progressive resistance training in breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat 2014; 148: 249-268
• 15 Bergenthal N, Will A, Streckmann F. et al. Aerobic physical exercise for adult patients with haematological malignancies. Cochrane Database Syst Rev 2014; (11) CD009075
• 16 Mirsoian A, Murphy WJ. Obesity and cancer immunotherapy toxicity. Immunotherapy 2015; 7: 319-322
• 17 Effertz T, Engel S, Verheyen F. et al. The costs and consequences of obesity in Germany: a new approach from a prevalence and life-cycle perspective. Eur J Health Econ 2016; 17: 1141-1158